Innovative Product Line Vasorum's flagship Celt ACD® arterial puncture closure device is a proven, best-in-class solution with over 30,000 patient implants worldwide, demonstrating strong market acceptance and reliability in vascular closure applications.

Market Expansion The company has successfully launched the second-generation Celt ACD® device in both the EU and US markets, indicating active efforts to grow its geographic presence and increase adoption among interventional cardiology and vascular procedures.

Funding & Growth Potential With recent equity investments totaling $7.3M and a focus on innovative device development, Vasorum presents opportunities for sales partners to introduce advanced vascular closure solutions and leverage its growth capital for expanding distribution channels.

Focus on Regulatory Approval Having received PMA and CE Mark approvals, Vasorum adheres to strict regulatory standards, enabling sales teams to confidently position Celt ACD® as a compliant and reliable device suitable for markets requiring high safety and efficacy standards.

Strategic Leadership and R&D Led by industry veterans and supported by a purpose-built facility with advanced manufacturing and testing equipment, Vasorum is well-positioned for ongoing product innovation, providing opportunities for sales collaborations around next-generation vascular closure technology.